Ривароксабан Чайкафарма

Ривароксабан Чайкафарма is an oral anticoagulant used to reduce blood clot risk. It belongs to the factor Xa inhibitor class, helping prevent stroke and systemic embolism in patients with atrial fibrillation. This EU-manufactured medication is taken by mouth for broad anticoagulation support.

Ривароксабан Чайкафарма is prescribed to lower the risk of blood clots forming in the body. It is commonly used in people with atrial fibrillation to prevent strokes and systemic embolism. The medication works by inhibiting factor Xa, a key enzyme in the clotting cascade. It may also be used after certain surgeries to reduce clot-related complications.

As an anticoagulant, Ривароксабан Чайкафарма helps maintain normal blood flow by reducing excessive clotting tendencies. Users may notice improved circulation and a lowered risk of clot-related symptoms such as swelling or pain in the legs. Regular use supports vascular health by preventing harmful clot formation.

Keep Ривароксабан Чайкафарма in a secure place away from children and pets. Store at room temperature, away from moisture and direct light. Inform your healthcare provider about all medications and supplements you take before starting this treatment. Avoid sudden changes in diet, especially regarding vitamin K intake, unless advised otherwise.

Ривароксабан Чайкафарма may interact with other drugs that affect blood clotting, such as NSAIDs, aspirin, or certain antibiotics. Herbal supplements like St. John’s wort and grapefruit products can also influence its effects. Always consult a healthcare professional before combining medications to avoid increased bleeding risk.